State Key Laboratory of Drug Research, Shanghai Institute of Materia Medica, Chinese Academy of Sciences, 555 Zu Chong Zhi Road, Zhangjiang Hi-Tech Park, Shanghai 201203, China.
Nano Science and Technology Institute, University of Science and Technology of China, 166 Ren Ai Road, Suzhou 215123, China.
Mar Drugs. 2018 Mar 20;16(3):97. doi: 10.3390/md16030097.
Phidianidines A and B are two novel marine indole alkaloids bearing an uncommon 1,2,4-oxadiazole ring and exhibiting various biological activities. Our previous research showed that the synthesized phidianidine analogs had the potential to inhibit the activity of protein tyrosine phosphatase 1B (PTP1B), a validated target for Type II diabetes, which indicates that these analogs are worth further structural modification. Therefore, in this paper, a series of phidianidine derivatives were designed and rapidly synthesized with a function-oriented synthesis (FOS) strategy. Their inhibitory effects on PTP1B and T-cell protein tyrosine phosphatase (TCPTP) were evaluated, and several compounds displayed significant inhibitory potency and specific selectivity over PTP1B. The structure-activity relationship (SAR) and molecular docking analyses are also described.
菲定碱 A 和 B 是两种新型海洋吲哚生物碱,具有不常见的 1,2,4-噁二唑环,并表现出多种生物活性。我们之前的研究表明,合成的菲定碱类似物具有抑制蛋白酪氨酸磷酸酶 1B(PTP1B)活性的潜力,PTP1B 是 II 型糖尿病的一个已验证的靶点,这表明这些类似物值得进一步进行结构修饰。因此,在本文中,我们采用面向功能的合成(FOS)策略设计并快速合成了一系列菲定碱衍生物。评估了它们对 PTP1B 和 T 细胞蛋白酪氨酸磷酸酶(TCPTP)的抑制作用,一些化合物对 PTP1B 表现出显著的抑制活性和特异性选择性。还描述了构效关系(SAR)和分子对接分析。